Medicinal and agrochemical products can be granted a Supplementary Protection Certificate, an intellectual property right associated with patents, to provide up to five years of additional rights and protections once their patents have expired. In order to apply for an SPC, a product must receive approval to be sold on the UK market. Under the Northern Ireland/Ireland Protocol, products to be sold in Northern Ireland must obtain approval under EU law, whilst products to be sold in the rest of the UK will obtain approval under UK law. Currently, this marketing authorisation is only given on a UK-wide basis. This regulation amends the market authorisation process to enable authorisations to be granted for the Northern Ireland market only and for the Great Britain market only.
Documents to download
-
Debate on 13 January: Economic and Strategic Role of Turkey (330 KB, PDF)
This Library Note summarises some of the key issues regarding the economic and strategic importance of Turkey. It also outlines some of the recent developments in Turkey’s accession negotiations with the European Union.
Documents to download
-
Debate on 13 January: Economic and Strategic Role of Turkey (330 KB, PDF)
Related posts
-
-
The Audiovisual Media Services (Amendment) (EU Exit) Regulations 2020 govern how on-demand programming and video-sharing platforms will be regulated after the Brexit transition period ends.
-
The regulation of product safety, and weights and measures, is based on EU law. The European Union (Withdrawal) Act 2018 brings this EU law into UK statute, so that it will continue to have effect after the end of the transition period. Amendments since have made to enable this framework to operate smoothly in the UK, and added provisions such as a UK conformity mark. This article looks at a further statutory instrument that amends retained EU law in the area, particularly in light of the Northern Ireland Protocol.
